Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.41
-0.19 (-2.21%)
Apr 29, 2026, 9:59 AM EDT - Market open
Immix Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -29.44 | -21.61 | -15.43 | -8.23 | -24.38 | |
| Depreciation & Amortization | 0.36 | 0.12 | 0.01 | 0 | 0 | |
| Other Amortization | - | - | - | - | 0.06 | |
| Stock-Based Compensation | 2.44 | 3.02 | 2.57 | 0.62 | 0.22 | |
| Other Operating Activities | - | -0.08 | -0.17 | - | 22.91 | |
| Change in Accounts Payable | 1.03 | 4.4 | 2.43 | 1.13 | -0.11 | |
| Change in Income Taxes | 2.06 | -0.97 | -0.89 | -0.24 | 0.1 | |
| Change in Other Net Operating Assets | -0.38 | 0.54 | 0.11 | -0.7 | -0.38 | |
| Operating Cash Flow | -23.93 | -14.6 | -11.37 | -7.41 | -1.59 | |
| Capital Expenditures | -0.73 | -1.18 | -0.05 | - | -0 | |
| Investment in Securities | -6.48 | - | - | - | - | |
| Investing Cash Flow | -7.21 | -1.18 | -0.05 | - | -0 | |
| Long-Term Debt Issued | - | - | - | - | 0.2 | |
| Total Debt Issued | - | - | - | - | 0.2 | |
| Short-Term Debt Repaid | - | - | - | -0.05 | - | |
| Total Debt Repaid | - | - | - | -0.05 | - | |
| Net Debt Issued (Repaid) | - | - | - | -0.05 | 0.2 | |
| Issuance of Common Stock | 107.52 | 15.95 | 15.52 | 2.91 | 18.65 | |
| Repurchase of Common Stock | - | - | - | -0.1 | - | |
| Other Financing Activities | -0.14 | - | -0.06 | 0.47 | - | |
| Financing Cash Flow | 107.39 | 15.95 | 15.46 | 3.23 | 18.85 | |
| Foreign Exchange Rate Adjustments | 0 | -0 | 0.03 | -0.03 | -0.01 | |
| Net Cash Flow | 76.25 | 0.17 | 4.07 | -4.21 | 17.25 | |
| Free Cash Flow | -24.66 | -15.77 | -11.42 | -7.41 | -1.59 | |
| Free Cash Flow Per Share | -0.75 | -0.56 | -0.66 | -0.53 | -0.43 | |
| Cash Interest Paid | - | - | - | 0.01 | 0 | |
| Levered Free Cash Flow | -13.61 | -7.55 | -5.94 | -4.31 | -2.1 | |
| Unlevered Free Cash Flow | -13.61 | -7.55 | -5.94 | -4.31 | -2.04 | |
| Change in Working Capital | 2.7 | 3.97 | 1.65 | 0.2 | -0.39 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.